BWM
ARNA

Baystate Wealth Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Baystate Wealth Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-5
Closed -$1K – 690
2017
Q3 		$1K Buy
+5
New +$115 ﹤0.01% 618

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baystate Wealth Management's ARNA Position: Q4 2017 in Review

Baystate Wealth Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2017, closing a stake of 5 shares — an estimated $1K sold.

Baystate Wealth Management first reported a position in ARNA in Q3 2017 and held it in 1 quarter. The position peaked at $1K in Q3 2017. 125 funds tracked by Wall St. Rank hold ARNA as of Q4 2017.

  • Baystate Wealth Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
  • Baystate Wealth Management sold 5 Arena Pharmaceuticals Inc shares in Q4 2017, an estimated $1K.
  • Baystate Wealth Management first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and held it in 1 quarter.
  • Baystate Wealth Management's Arena Pharmaceuticals Inc position peaked at $1K in Q3 2017.
  • 125 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2017.

Based on Baystate Wealth Management's 13F filing for Q4 2017, filed 23 Jan 2018.